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Introduction
The genomes of all living cells are under continuous attack from 
a variety of endogenous and exogenous DNA-damaging agents, 
which lead to many types of DNA lesions. These DNA lesions 
can block genome replication and transcription and, if not re-
paired, yield mutations or wilder scale genome aberrations that 
threaten the survival of the individual cells and the whole or-
ganism. To counteract the deleterious effects of damaged DNA, 
organisms have evolved a variety of surveillance and repair mecha-
nisms (Jackson and Bartek, 2009; Ciccia and Elledge, 2010). 
Translesion DNA synthesis (TLS) is a universal DNA damage 
tolerance mechanism conserved from yeast to mammals and per-
formed by a class of specialized DNA polymerases (Friedberg, 
2005; Lehmann et al., 2007; Moldovan et al., 2007). These TLS 
polymerases possess a spacious active site and are capable of 
accommodating a variety of DNA lesions that would block the 
high-fidelity replicative DNA polymerases (Prakash et al., 2005). 
Most of the TLS polymerases belong to the Y family, which 
includes Pol (polymerase ), Pol, Pol, and Rev1 (Ohmori 
et al., 2001; Sale et al., 2012). Studies have shown that TLS is 
accomplished by the concerted action of multiple TLS polymer-
ases. Remarkably, human DNA Pol is able to replicate past a 
cis-syn thymine–thymine (TT) dimer, a major photoproduct in-
duced by UV irradiation, as efficiently as past undamaged DNA 
(McCulloch et al., 2004). Inactivation of Pol in humans causes 
the variant form of the skin cancer-prone syndrome xeroderma 
pigmentosum (XP-V; Johnson et al., 1999; Masutani et al., 1999a,b; 
Bienko et al., 2010). Cells from XP-V individuals are deficient 
in the replication of UV-damaged DNA and show hypermuta-
bility after UV exposure (Lehmann et al., 1975; Maher et al., 1976; 
Masutani et al., 1999b; Bienko et al., 2010).
A key event in the regulation of TLS is the monoubiquitina-
tion of proliferating cell nuclear antigen (PCNA), a homotrimeric 
protein that acts as an auxiliary factor for DNA polymerases 
(Hoege et al., 2002; Stelter and Ulrich, 2003; Moldovan et al., 
2007). In response to DNA damage and/or replication stress, 
PCNA is monoubiquitinated at the lysine 164 residue by the 
E2 ubiquitin-conjugating enzyme RAD6 and the E3 ubiqui-
tin ligase RAD18 (Hoege et al., 2002; Watanabe et al., 2004; 
Lehmann, 2011). PCNA can also be monoubiquitinated by the 
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Figure 1. Identification of SIVA1 as PCNA-binding partner. (A and D) HEK293T cells stably expressing either the vector control or SFB-tagged (S tag, Flag 
epitope tag, and streptavidin-binding peptide tag) PCNA/SIVA1 were used for tandem affinity purification of protein complexes. The final eluates were 
resolved on SDS-PAGE gels and Coomassie stained. (B and E) Tables are summaries of proteins identified by mass spectrometry analysis. Letters in bold 
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from HEK293T cells ectopically expressing SFB (streptavidin-
Flag–S protein)-tagged wild-type PCNA (Fig. 1 A). Mass spec-
trometry analysis identified many known PCNA-binding proteins, 
including PAF15, FEN1, and replication factor C (RFC) complex 
(Fig. 1 B; Emanuele et al., 2011; Povlsen et al., 2012). Interest-
ingly, we also repeatedly identified SIVA1 as a putative PCNA-
binding protein (Fig. 1 B). The presence of SIVA1 in PCNA–protein 
complexes was confirmed by Western blotting (Fig. 1 C).
To ensure that SIVA1 indeed forms a complex with PCNA, 
we performed reverse tandem affinity purification using HEK293T 
cells stably expressing SFB-tagged SIVA1 and identified PCNA 
as a major SIVA1-associated protein (Fig. 1, D and E). The 
presence of PCNA in SIVA1 purification was also confirmed by 
Western blotting (Fig. 1 F). Collectively, these results indicate 
that SIVA1 is a bone fide PCNA-interacting protein.
SIVA1 interacts with PCNA in vivo  
and in vitro
To verify our tandem affinity purification results, we performed co-
immunoprecipitation assays using SFB-tagged SIVA1 and Myc-
tagged PCNA. We found that SIVA1, like p21, interacts strongly 
with PCNA (Fig. S1 A). In contrast, the unrelated control protein 
Morc3 (Takahashi et al., 2007) does not interact with PCNA 
(Fig. S1 A). We further performed coimmunoprecipitation experi-
ments and confirmed the interaction between endogenous SIVA1 
and PCNA (Fig. 1, G and H; and Fig. S1, B and C). The SIVA1–
PCNA complex formation was DNA damage independent, and this 
preexisting complex could be detected in HeLa cells (Fig. S1 D) as 
well as in other cell lines including HEK293T cells (Fig. S1 E).
We next tested the possibility that there could be a direct 
protein–protein interaction between PCNA and SIVA1. Pull-down 
assays using recombinant maltose-binding protein (MBP)–tagged 
PCNA and GST-tagged SIVA1 purified from Escherichia coli dem-
onstrated that SIVA1 binds directly to PCNA in vitro (Fig. 1 I).
PCNA and several other proteins involved in DNA me-
tabolism could form discrete foci in the nucleus. Given that 
SIVA1 forms a complex with PCNA, we speculate that SIVA1 
may colocalize with PCNA at nucleus foci. As expected, SIVA1 
could form discrete nuclear foci and colocalized with PCNA 
(Fig. 1 J). Collectively, these results established that SIVA1 
binds PCNA and suggested an involvement for SIVA1 protein 
in PCNA-mediated cellular processes.
PCNA regulates SIVA1 protein stability
The stability of one component in a multiprotein complex often 
depends on the presence of other components so that when one 
CRL4(Cdt2) E3 ubiquitin ligase in the absence of external DNA 
damage (Terai et al., 2010). In mammals, monoubiquitinated 
PCNA has been reported to have a much higher affinity than 
unmodified PCNA for Pol (Haracska et al., 2001a; Kannouche 
et al., 2004; Watanabe et al., 2004; Terai et al., 2010). This is 
in line with the identification of ubiquitin-binding domains in 
all Y family polymerases that might contribute to the increased 
interaction of PCNA and TLS polymerases after UV irradiation 
(Haracska et al., 2001b, 2002; Bienko et al., 2005; Plosky et al., 
2006; Schmutz et al., 2010). Because untimely DNA synthesis 
by low-fidelity TLS polymerases could result in a higher muta-
genesis rate, monoubiquitination of PCNA is kept in check by 
the USP1–UAF1 deubiquitinase complex (Huang et al., 2006; 
Cohn et al., 2007; Kim et al., 2009). Depletion of USP1 or UAF1 
in human cells results in increased levels of monoubiquitinated 
PCNA both in the presence and absence of DNA damage (Huang 
et al., 2006; Cohn et al., 2007; Kim et al., 2009). There is grow-
ing evidence that the level of monoubiquitinated PCNA is closely 
linked with the DNA damage bypass to protect cells from a high 
level of mutagenesis. However, it still remains unclear how the 
level of monoubiquitinated PCNA is regulated.
SIVA1 is a small protein originally identified as an intracel-
lular ligand for CD27 (Prasad et al., 1997; Xue et al., 2002). The 
structure of SIVA1 protein contains a death domain homology 
region in the central part and two zinc finger–like cysteine-rich 
domains in the C terminus (Prasad et al., 1997; Xue et al., 2002). 
SIVA1 plays a role both in extrinsic and intrinsic apoptotic path-
ways (Prasad et al., 1997; Xue et al., 2002; Resch et al., 2009). 
Recently, SIVA1 has also been shown to act as a suppressor of 
p53 (Du et al., 2009; Wang et al., 2013). Here, we identified 
SIVA1 as a critical regulator of PCNA monoubiquitination in 
response to UV-induced DNA damage. SIVA1 specifically in-
teracts with RAD18 and PCNA in vivo and in vitro and displays 
properties of a substrate-specific adaptor. Depletion of SIVA1 
compromised RAD18-dependent PCNA monoubiquitination and 
Pol focus formation, leading to increased UV sensitivity and 
mutation frequency. Our results provide new insights into the 
molecular mechanism that regulates PCNA monoubiquitination 
and TLS in response to UV damage.
Results
Identification of SIVA1 as  
a PCNA-binding protein
To identify previously undetected interacting partners of PCNA, 
we performed tandem affinity purification using lysates prepared 
indicate the bait proteins. (C and F) Confirmation of PCNA- or SIVA1-interacting proteins by Western blotting. PCNA/SIVA1 purification products were 
analyzed by Western blots using specific antibodies against Flag, SIVA1, or PCNA. (G and H) Association of endogenous SIVA1 with PCNA in HeLa cells 
was performed by coimmunoprecipitation using the anti-SIVA1 or anti-PCNA antibody. SiRNA-treated HeLa cells were lysed in the presence of Benzonase, 
cell lysates were then incubated with protein A agarose beads conjugated with the indicated antibodies, and Western blot analysis was performed accord-
ing to standard procedures. siCon, control siRNA. (I) Direct in vitro binding between recombinant MBP-PCNA and GST-SIVA1 purified from E. coli. GST 
served as negative control for PCNA binding. (top) PCNA was detected by immunoblotting. (bottom) Purified proteins visualized by Coomassie staining. 
(J) SIVA1 colocalizes with PCNA at nucleus foci. HeLa cells were transfected with HA-Flag–tagged SIVA1 plasmids. 24 h after transfection, cells were 
treated with 50 J/m2 UV or left untreated. After 1 h recovery, foci assembled by this fusion protein and by PCNA were detected by immunofluorescence 
using anti-Flag and anti-PCNA antibodies, respectively. HA-Flag–SIVA1 foci were detected in red, whereas PCNA foci were detected in green. A merged 
image shows colocalization. IP, immunoprecipitation. Bar, 10 µm.
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In response to UV damage, PCNA can be monoubiqui-
tinated at K164 by E3 ubiquitin ligase RAD18 (Hoege et al., 
2002; Watanabe et al., 2004; Lehmann, 2011). We therefore tested 
whether the ubiquitination status of PCNA plays a role in stabi-
lizing SIVA1. As shown in Fig. 2 E, depletion of RAD18, which 
abolished PCNA monoubiquitination after UV treatment, has 
no effect on SIVA1 protein stability, indicating that RAD18-
mediated PCNA monoubiquitination is not required for main-
taining the steady-state levels of SIVA1.
protein is depleted, the others become unstable and show re-
duced expression levels. Indeed, reduction of PCNA expression 
by shRNAs in cells led to a dramatic decrease in SIVA1 protein 
level but not in mRNA level (Fig. 2, A and B). Moreover, this 
decrease was partially rescued by treatment with the proteasome 
inhibitor MG132 (Fig. 2 C). In contrast, depletion of SIVA1 
did not affect the stability of PCNA (Fig. 2 D). Together, these 
results suggest that SIVA1 is normally stabilized in vivo by PCNA 
but not vice versa.
Figure 2. PCNA regulates the stability of SIVA1. (A) PCNA 
depletion decreases the stability of SIVA1. HeLa cells were 
infected with lentiviruses carrying nontarget control or PCNA-
specific shRNAs. 48 h later, cell lysates were subjected to 
immunoblotting using the indicated antibodies. (B) PCNA 
depletion has no effect on SIVA1 mRNA levels. HeLa cells 
were infected with lentiviruses carrying nontarget control 
or PCNA-specific shRNAs. 48 h later, the levels of specific 
mRNAs were determined by quantitative RT-PCR. Bars repre-
sent the mean of three experiments, and error bars are SDs. 
(C) MG132 treatment partially rescues the levels of SIVA1 
protein in PCNA-depleted cells. HeLa cells were infected 
with lentiviruses carrying nontarget control or PCNA-specific 
shRNAs. 48 h later, cells were treated with proteasome inhib-
itor MG132 (10 µM) or DMSO for 6 h. Cell lysates were then 
subjected to immunoblotting using the indicated antibodies. 
(D) SIVA1 depletion has no effect on PCNA protein stabil-
ity. HeLa cells were transfected twice with control siRNA 
or siRNAs specific for SIVA1. Cell lysates prepared 48 h 
after the second transfection were analyzed by immunoblot-
ting with the indicated antibodies. (E) RAD18 depletion has 
no effect on SIVA1 protein stability. HeLa cells transfected 
with control siRNA or siRNAs specific for RAD18 were treated 
with 50 J/m2 UV for 1 h or left untreated. Cell lysates were 
then analyzed by immunoblotting with indicated antibodies. 
ShCon, control shRNA; SiCon, control siRNA; ub, ubiquitin.
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efficient Pol foci formation, we sought to examine whether 
SIVA1 depletion affects DNA damage-induced CHK1 phosphory-
lation. As shown in Fig. S3 A, SIVA1 depletion, like RAD18 
depletion, resulted in prolonged phosphorylation of CHK1 after 
UV damage.
To further test whether the PIP motif is important for SIVA1 
function in vivo, we generated a XP30RO-Pol cell line to 
stably express siRNA#1-resistant wild-type SIVA1 or its point 
mutants defective in PCNA binding and examined Pol focus 
formation. The expression of exogenous SIVA1 or SIVA1 mu-
tants was confirmed by immunoblotting in the cells transfected 
with control siRNA or SIVA1 siRNA#1 (Fig. 4 E). Notably, the 
expression level of both the SIVA1 mutants defective in PCNA 
binding (Q85A and I88A) is significantly lower than that of wild 
type (Fig. 4 E). This finding further supports our conclusion that 
SIVA1 is normally stabilized in vivo by PCNA (Fig. 2 A). Ac-
cordingly, the defect of Pol foci formation in SIVA1-depleted 
cells was readily restored by the reexpression of wild-type 
SIVA1 but not the point mutants defective in PCNA binding 
(Fig. 4 F and Fig. S3 B).
Depletion of SIVA1 causes increased 
mutation frequency
Cells deficient in Pol exhibit hypersensitivity to UV damage 
and display elevated mutation frequency. Given that SIVA1 is 
required for efficient recruitment of Pol to sites of UV-induced 
DNA damage, we propose that SIVA1 may also be involved in 
mutagenesis suppression. To test this possibility, we measured 
the mutation frequency using the pZ189 shuttle vector system 
(Akasaka et al., 1992). As shown in Fig. 4 (G and H), the muta-
tion frequency in SIVA1-depleted cells was dramatically ele-
vated. Moreover, codepletion of SIVA1 and Pol did not cause 
a further increase in mutation frequency, suggesting that SIVA1 
and Pol may operate in the same pathway (Fig. 4, G and H).
SIVA1 is required for efficient PCNA 
monoubiquitination
RAD18/RAD6-dependent monoubiquitination of PCNA at 
Lys164 (K164) is thought to promote direct lesion bypass by 
recruiting TLS polymerases to the stalled replication forks. The 
association of SIVA1 with PCNA and the requirement of SIVA1 
for Pol recruitment raised the intriguing possibility that SIVA1 
may play a critical role in PCNA monoubiquitination. In agree-
ment with this idea, SIVA1 depletion results in a dramatic re-
duction in the level of PCNA monoubiquitination (Fig. 5 A). 
Importantly, suppression of SIVA1 expression did not markedly 
alter the cell cycle distribution (Fig. S3 C), suggesting that these 
observed phenotypes in SIVA1 knockdown cells were not caused 
by any change in cell cycle.
It is well established that the level of PCNA monoubiq-
uitination is regulated by both the RAD18–RAD6 ubiquitin 
ligase complex and the USP1–UAF1 deubiquitinase complex. 
The requirement of SIVA1 for the efficient monoubiquitination 
of PCNA suggests that it either positively regulates ubiquitin 
ligation or negatively regulates USP1–UAF1 via direct or indirect 
mechanisms. If SIVA1 positively regulates ubiquitin ligation, 
depletion of SIVA1 will compromise PCNA monoubiquitination 
SIVA1 interacts with PCNA via a putative 
PCNA-interacting peptide (PIP) box
We next mapped the regions within SIVA1 responsible for its 
interaction with PCNA by using SFB-tagged wild-type SIVA1 
and a series of SIVA1 deletion mutants (Fig. 3 A). Coimmuno-
precipitation experiments revealed that a domain spanning amino 
acids 83–96 of SIVA1 contributes to its interaction with PCNA 
(Fig. 3 B). Consistently, whereas purified recombinant wild-type 
SIVA1 and the other mutants were able to pull-down endogenous 
PCNA from HEK293T cell extracts very efficiently, the SIVA1-5 
mutant failed to do so (Fig. 3 C). Interestingly, this region of 
SIVA1 (residues 83–96) has been highly conserved throughout 
evolution, suggesting that it may carry out an important func-
tion of SIVA1 (Fig. 3 D).
Many PCNA-associated proteins have been shown to inter-
act with PCNA via their corresponding PIP box, which has the 
consensus motif QXX(M/L/I)XX(F/Y)(F/Y). During visual in-
spection of the SIVA1 amino acid sequence, we identified a po-
tentially divergent PIP box that coincided with the region required 
for its interaction with PCNA (Fig. 3 D). To test whether SIVA1 
might similarly interact with PCNA via its putative PIP box, we 
generated two point mutants with mutations within the consen-
sus PIP box (Q85A and I88A; Fig. 3 D). As shown in Fig. 3 E, 
whereas wild-type SIVA1 was able to interact with PCNA, both 
the Q85A and I88A mutants failed to do so. Furthermore, pull-
down experiments consolidated the aforementioned notion that 
SIVA1 interacts with PCNA via its PIP box (Fig. 3 F).
SIVA1 is required for Pol recruitment 
after UV damage
To investigate the cellular function of SIVA1, we knocked 
down its expression in human HeLa cells using two independent 
siRNAs specifically targeting SIVA1. Interestingly, SIVA1 
knockdown cells showed significantly elevated sensitivity to 
UV as compared with cells treated with control siRNA (Fig. 4 A). 
SIVA1 knockdown cells, however, showed little or no hyper-
sensitivity to mitomycin C (MMC) and hydroxyurea (HU), sug-
gesting a specific involvement of SIVA1 in the response to 
UV-induced DNA damage (Fig. 4 A).
A major universal tolerance mechanism is TLS, in which 
specialized low-fidelity DNA polymerases elongate the DNA 
across the lesion. To investigate how SIVA1 contributes to the 
repair and/or tolerance of UV damage, we engineered a Pol-
deficient XP30RO cell line to express SFB-tagged Pol (XP30RO-
Pol) under the control of a tetracycline-inducible promoter 
(Fig. S2, A and B) and tested the effect of SIVA1 depletion on 
the ability of Pol to form foci after UV irradiation. Remarkably, 
depletion of SIVA1 significantly reduced UV-induced Pol focus 
formation (Fig. 4, B–D). Similar results were also obtained with 
HeLa cells (Fig. S2, C–E). These results suggest that SIVA1 may 
confer cellular resistance to UV radiation by promoting recruit-
ment of Pol to the sites of UV-induced DNA damage.
Previous studies have shown that genotoxin-induced CHK1 
activation in TLS-deficient cells is exacerbated and that this may 
be a result of the persistence of unfilled postreplicative single-
stranded gaps (Bi et al., 2005, 2006; Lopes et al., 2006; Callegari 
et al., 2010; Yang et al., 2013). Because SIVA1 is required for 
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Figure 3. The PIP box of SIVA1 is responsible for PCNA binding. (A) Schematic representation of wild-type and deletion mutants of SIVA1 used in this 
study. (B) Residues 83–96 of SIVA1 are responsible for PCNA binding. HEK293T cells were transiently transfected with plasmids encoding tagged PCNA 
and SIVA1. Cell lysates were immunoprecipitated with S beads, and Western blot analysis was performed with anti-Flag and anti-Myc antibodies. (C) Puri-
fied GST, GST-tagged wild-type SIVA1, or its deletion mutants immobilized on Sepharose beads were incubated with HEK293T cell lysates. Endogenous 
bound PCNA was analyzed by anti-PCNA immunoblotting. Input GST or GST-SIVA1 proteins were shown at the bottom. (D) Sequence alignment of the 
PCNA-binding region in SIVA1 from different species. (E and F) The PIP box of SIVA1 is required for SIVA1 to bind to PCNA. HEK293T cells were trans-
fected with plasmids encoding SFB-tagged wild-type SIVA1 or two PIP box mutants (Q85A and I88A) together with plasmids encoding Myc-tagged PCNA. 
(E) Coprecipitation was performed using S protein beads, and immunoblotting was performed using antibodies as indicated. (F) Purified GST or GST-
tagged wild-type SIVA1 or two PIP box mutants (Q85A and I88A) immobilized on Sepharose beads were incubated with HEK293T cell lysates. Endog-
enous bound PCNA was analyzed by anti-PCNA immunoblotting. IP, immunoprecipitation; WT, wild type.
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Figure 4. SIVA1 regulates localization of Pol. (A) Clonogenic survival assays in SIVA1-depleted HeLa cells after UV, MMC, or HU treatment. RAD18 
depletion is used as a positive control. Cells were permitted to grow for 14 d before staining. Experiments were performed in triplicates. Results shown are 
means of three independent experiments and were presented as means ± SD. (B–D) SIVA1 is required for Pol foci formation. A XP30RO cell line to express 
SFB-tagged Pol (XP30RO-Pol) under the control of a tetracycline-inducible promoter was generated. The resulting cell line was transfected twice with the 
indicated siRNAs and was induced by 1 µg/ml doxycycline addition for 24 h before 50 J/m2 UV treatment. Cells were then fixed and processed for Pol  
immunofluorescence. (B) Representative Pol foci were shown. (C) Quantification results were the mean of three independent experiments and were pre-
sented as means ± SD. More than 100 cells were counted in each experiment. (D) Knockdown efficiency was confirmed by immunoblotting. (E and F) PIP 
box mutants of SIVA1 could not rescue Pol foci formation in SIVA1-depleted cells. XP30RO-Pol–derivative cell lines stably expressing HA-tagged 
siRNA#1-resistant wild-type SIVA1 or two PIP box mutants (Q85A and I88A) were generated. The resulting cell line was transfected twice with the indicated 
siRNAs and was induced by doxycycline addition for 24 h before 50 J/m2 UV treatment. 4 h later, cells were fixed and processed for Pol immunofluorescence. 
(F) Representative Pol foci were shown. (E) The exogenous SIVA1 expression was confirmed by immunoblotting using the anti-HA antibody. (G and H) HEK293T 
cells transfected with the indicated siRNAs for 48 h were treated with UV-damaged supF plasmid. After a further 48 h, the supF plasmid was recovered, and supF 
mutation frequencies were measured from 10,000 colonies. (G) Results were the mean of three independent experiments and were presented as means ± SD. 
(H) Knockdown efficiency was confirmed by immunoblotting. SiCon, control siRNA; SiR, siRNA resistant; WT, wild type. Bars, 10 µm.
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Figure 5. SIVA1 is required for efficient PCNA monoubiquitination. (A) SIVA1 is required for UV-induced PCNA monoubiquitination. HeLa cells were 
transfected twice with control siRNA or siRNAs specific for SIVA1. 48 h after transfection, cells were untreated or treated with 50 J/m2 UV for the indicated 
times. Chromatin fractions were isolated and immunoblotted with the indicated antibodies. (B and C) HeLa cells were transfected twice with the indicated 
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experiments and found that a domain spanning amino acids 
40–58 of SIVA1 is responsible for RAD18 binding (Fig. 6 C). 
Conversely, we generated a series of RAD18 deletion mutants 
to examine which domain of RAD18 might be required for its 
interaction with SIVA1. Interestingly, the RAD18 region that 
mediates its binding to SIVA1 is located at residues 331–375 
and thus overlaps with the RAD18 binding region to RAD6 
(Fig. S4; Bailly et al., 1997; Watanabe et al., 2004).
To test whether SIVA1 binding to RAD18 through a di-
rect interaction, an in vitro GST pull-down assay was performed 
using GST-fused SIVA1 and His-small ubiquitin-like modifier 
(SUMO)–fused RAD18 recombinant proteins (Hibbert et al., 
2011). Notably, His-SUMO–RAD18 could be pulled down by 
GST-SIVA1 but not by GST alone (Fig. 6 D), suggesting that 
SIVA1 directly interacts with RAD18. Moreover, consistent 
with the results of coimmunoprecipitation experiments, the 
GST–SIVA1-2 fusion protein failed to pull down His-SUMO–
RAD18 (Fig. 6 D).
The association of SIVA1 with RAD18 and PCNA through 
nonoverlapping regions and the similar effects of SIVA1 and 
RAD18 on PCNA monoubiquitination raised the intriguing 
possibility that SIVA1 might facilitate the RAD18–PCNA inter-
action in the cells, thus leading to PCNA monoubiquitination. 
In a mammalian overexpression system, RAD18 interacted with 
PCNA weakly, probably through endogenous SIVA1. This inter-
action was enhanced by ectopically expressed SIVA1 (Fig. 6 E). 
In untransfected cells, endogenous RAD18 interacted with 
PCNA in a UV-dependent manner, and this interaction was di-
minished by knockdown of SIVA1 (Fig. 6 F). Moreover, the 
SIVA1–PCNA interaction was not affected when RAD18 was 
ablated by siRNA (Fig. 6 G). These results suggest that SIVA1 
is the central component of the RAD18–SIVA1–PCNA complex 
and physically connects RAD18 to PCNA in vivo. In agreement 
with this conclusion, the recombinant SIVA1 protein facilitated 
RAD18–PCNA complex assembly in vitro (Fig. 6 H).
SIVA1 promotes RAD18-mediated PCNA 
monoubiquitination in vivo and in vitro
As shown in Fig. 5 A and Fig. 6 (E–H), SIVA1 mediates the 
interaction between RAD18 and PCNA and is required for effi-
cient PCNA monoubiquitination. Therefore, it would be inter-
esting to test whether SIVA1 can promote RAD18-mediated 
PCNA monoubiquitination. We first investigated RAD18- 
mediated monoubiquitination of PCNA in cells overexpressing 
SIVA1. As we expected, RAD18-mediated monoubiquitination 
of PCNA was significantly enhanced in SIVA1-overexpressed 
cells compared with that in control cells both in the presence 
and absence of UV treatment (Fig. 7 A).
even in the absence of USP1. On the other hand, if SIVA1 nega-
tively regulates USP1–UAF1, depletion of SIVA1 will not affect 
PCNA monoubiquitination in the absence of USP1. To test these 
possibilities, we first analyzed the monoubiquitination of PCNA 
in SIVA1 and USP1 single and double knockdown cells. Con-
sistent with previous findings (Huang et al., 2006; Cohn et al., 
2007; Kim et al., 2009), depletion of USP1 by using siRNA 
results in increased levels of monoubiquitinated PCNA both 
in the absence and presence of UV damage (Fig. 5, B and C). 
Interestingly, like that of RAD18, depletion of SIVA1 compro-
mised PCNA monoubiquitination even when USP1 was simul-
taneously depleted (Fig. 5, B and C). Consistently, depletion 
of SIVA1 compromised Pol focus formation when USP1 was 
simultaneously depleted (Fig. 5, D and E; and Fig. S3 D). These 
results, collectively with our observation that SIVA1 deple-
tion did not affect the chromatin association of USP1 and UAF1 
(Fig. 5 A), exclude the possibility that SIVA1 may act as an antag-
onist of PCNA deubiquitination by the USP1–UAF1 complex.
Next, we examined how SIVA1 facilitates the establish-
ment of PCNA monoubiquitination. Because PCNA mono-
ubiquitination occurs in a chromatin context, we asked whether 
SIVA1 regulates the chromatin association of RAD18 or RAD6, 
the ubiquitin-conjugating enzyme required for PCNA monou-
biquitination. Surprisingly, however, depletion of SIVA1 had 
no effect on the levels of chromatin-bound RAD18 and RAD6 
(Fig. 5 A). In addition, knockdown of SIVA1 did not affect the 
formation of RAD18 foci after UV treatment (Fig. 5, F and G). 
These results indicate that SIVA1 does not promote PCNA mono-
ubiquitination by facilitating the binding and/or retention of 
RAD18 and RAD6 on chromatin.
SIVA1 associates with and recruits 
RAD18 to PCNA
Substrate-specific receptors dictate the specificity for the ubiq-
uitination reaction by selectively recruiting substrates to the 
E3 ubiquitin ligase machinery. The observation that SIVA1 
interacts with PCNA and is required for efficient PCNA mono-
ubiquitination, despite normal RAD18 foci formation in SIVA1-
depleted cells, suggested that SIVA1 may serve as a substrate 
receptor for RAD18 ubiquitin ligase. To test this possibility, we 
first examined whether SIVA1 physically interacts with RAD18. 
Coimmunoprecipitation experiments showed that SFB-tagged 
RAD18 interacted with Myc-tagged SIVA1 (Fig. 6 A). We 
further demonstrated that endogenous RAD18 interacts with 
SIVA1 and that the interaction between SIVA1 and RAD18 is 
enhanced after UV treatment (Fig. 6, A and B).
To identify the regions within SIVA1 responsible for its 
interaction with RAD18, we performed coimmunoprecipitation 
siRNAs. 48 h after transfection, cells were untreated or treated with 50 J/m2 UV for 1 h. Chromatin fractions were isolated and immunoblotted with the 
indicated antibodies. (D and E) A HeLa cell line to stably express HA-Flag–tagged Pol was generated. The resulting cell line was transfected twice with the 
indicated siRNAs. 48 h after transfection, cells were untreated or treated with 50 J/m2 UV for the indicated times before fixing and processed for Pol immuno-
fluorescence. (E) Representative Pol foci were shown. (D) Quantification results were the mean of three independent experiments and were presented as 
means ± SD. More than 100 cells were counted in each experiment. (F and G) SIVA1 is not required for RAD18 foci formation. HeLa cells were transfected 
twice with control siRNA or siRNAs specific for SIVA1 or RAD18. 48 h after transfection, cells were treated with 50 J/m2 UV for 4 h before fixing and pro-
cessed for RAD18 immunofluorescence. (F) Representative RAD18 foci were shown. (G) Quantification results were the mean of three independent experiments 
and were presented as mean ± SD. More than 100 cells were counted in each experiment. SiCon, control siRNA; ub, ubiquitin. Bars, 10 µm.
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Figure 6. SIVA1 associates with and recruits RAD18 to PCNA. (A) SIVA1 interacts with RAD18. HEK293T cells were transiently transfected with plasmids 
encoding SFB-tagged Morc3 or RAD18 together with plasmids encoding Myc-tagged SIVA1. 24 h after transfection, cells were left untreated or treated 
with 50 J/m2 UV for 1 h. Coprecipitation was performed using S protein beads, and immunoblotting was performed using antibodies as indicated. 
(B) Association of endogenous SIVA1 with RAD18 in HeLa cells was analyzed by immunoprecipitation using the anti-SIVA1 antibody. Cells transfected 
with the indicated siRNAs were treated with 50 J/m2 UV for 1 h or left untreated and then lysed with NETN buffer containing Benzonase. Cell lysates were 
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wild-type SIVA1, but not the deletion mutants defective in RAD18 
binding, was able to restore PCNA monoubiquitination and Pol 
foci formation in SIVA1-depleted cells. These results indicate 
that the RAD18-binding activity is required for SIVA1 to func-
tion in vivo.
To further define the in vivo functional link between SIVA1 
and RAD18, we performed an epistasis analysis of the two pro-
teins. As shown in Fig. 8 (D and E), the UV hypersensitivity of 
cells depleted of both RAD18 and SIVA1 was not greater than 
when each protein was depleted individually, indicating that 
SIVA1 and RAD18 function in the same pathway.
Discussion
In this study, we have provided several lines of evidence to show 
that SIVA1 is a critical regulator of PCNA monoubiquitination 
in response to UV damage. First, SIVA1 constitutively interacts 
Next, we performed in vitro ubiquitination assays using 
PCNA as the substrate in the presence of wild-type or mutant 
SIVA1 along with the RAD18–RAD6 complex to examine whether 
SIVA1 can promote RAD18-mediated PCNA monoubiquitination 
in vitro. As expected, the recombinant RAD18–RAD6 complex 
was able to monoubiquitinate PCNA as shown by the appear-
ance of an electrophoretically shifted form of PCNA. Interest-
ingly, the ubiquitin-modified PCNA was significantly enhanced 
in the presence of recombinant wild-type SIVA1 but not the mu-
tants defective in PCNA or RAD18 binding (Fig. 7 B).
SIVA1 is functionally linked to RAD18
To investigate the biological significance of the interaction be-
tween SIVA1 and RAD18, we performed rescue experiments to 
examine whether the ability of SIVA1 to bind RAD18 is impor-
tant for its function in PCNA monoubiquitination and Pol foci 
formation. As shown in Fig. 8 (A–C) and Fig. S5, siRNA-resistant 
incubated with protein A agarose beads conjugated with indicated antibodies, and Western blot analysis was performed as indicated. (C) Residues 40–58 
of SIVA1 are responsible for RAD18 binding. HEK293T cells were transiently transfected with the indicated plasmids. 24 h after transfection, cells were 
treated with 50 J/m2 UV for 1 h. Coprecipitation was performed using S protein beads, and immunoblotting was performed using antibodies as indicated. 
(D) Direct in vitro binding between recombinant GST-SIVA1 and His-SUMO–RAD18 purified from E. coli. GST served as negative control for RAD18 bind-
ing. (top) RAD18 was detected by immunoblotting. (bottom) Purified proteins visualized by Coomassie staining. (E) Overexpression of SIVA1 enhances 
the interaction between RAD18 and PCNA. HEK293T cells were transiently transfected with the indicated plasmids. 24 h after transfection, cells were left 
untreated or treated with 50 J/m2 UV for 1 h. Coprecipitation was performed using S protein beads, and immunoblotting was performed using antibodies 
as indicated. (F) The RAD18–PCNA interaction is diminished in SIVA1-depleted cells. HeLa cells were transfected twice with control siRNA or siRNA specific 
for SIVA1. 48 h after transfection, cells were left untreated or treated with 50 J/m2 UV for 1 h. Cells were then Triton X-100 extracted and formaldehyde 
fixed, and cell lysates were immunoprecipitated with protein A agarose beads conjugated with anti-PCNA antibody. Western blot analysis was performed 
as indicated. (G) RAD18 depletion does not affect SIVA1–PCNA interaction. HeLa cells transfected with the indicated siRNAs were treated with 50 J/m2 UV 
for 1 h or left untreated and then lysed with NETN buffer containing Benzonase. Cell lysates were then incubated with protein A agarose beads conjugated 
with anti-SIVA1 antibody, and Western blot analysis was performed according to standard procedures. (H) SIVA1 facilitates RAD18–PCNA complex as-
sembly in vitro. (top) RAD18 and SIVA1 were detected by immunoblotting. (bottom) Purified proteins were visualized by Coomassie staining. Con, control; 
IP, immunoprecipitation; ub, ubiquitin; WT, wild type.
 
Figure 7. SIVA1 promotes PCNA monoubiquitination in vivo and in vitro. (A) SIVA1 promotes RAD18-mediated PCNA monoubiquitination in vivo. HeLa 
cells were transiently transfected with the indicated plasmids. 48 h after transfection, cells were left untreated or treated with 50 J/m2 UV for 1 h. Chromatin 
fractions were isolated and immunoblotted with the indicated antibodies. (B) SIVA1 promotes RAD18-mediated PCNA monoubiquitination in vitro. 0.4 µM 
PCNA was incubated in the absence or presence of various combinations of 50 µM ubiquitin, 50 nM Uba1, 0.2 µM RAD6, 0.2 µM RAD18, and SIVA1 
(0.5 µM or 1 µM) as indicated. The assay was performed in reaction buffer containing 25 mM Tris, pH 8.0, 50 mM NaCl, and 0.1 mM DTT. The reactions 
were activated with 2 mM ATP and incubated at 30°C for 1 h. Proteins were resolved by SDS-PAGE and immunoblotted with the indicated antibodies. 
ub, ubiquitin.
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Figure 8. SIVA1 is functionally linked to RAD18. (A) The mutant defective in RAD18 binding failed to rescue PCNA monoubiquitination in cells with SIVA1 
depletion. A HeLa cell line stably expressing HA-tagged siRNA#1-resistant wild-type SIVA1 (SiR-WT) or its deletion mutant defective in RAD18 binding (SiR-2) 
was generated. The resulting cell lines were transfected twice with control siRNA or SIVA1 siRNA#1. 48 h after the second transfection, cells were left 
untreated or treated with 50 J/m2 UV for 1 h. Chromatin fractions were isolated and immunoblotted with the indicated antibodies. (B and C) The mutant 
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have demonstrated that hELG1 specifically directs the USP1–
UAF1 complex to PCNA at the damage site and in doing so ini-
tiates the switch from the TLS polymerases to the replicative 
polymerases (Lee et al., 2010; Parnas et al., 2010; Yang et al., 
2011). It is apparent that the two scaffold proteins SIVA1 and 
hELG1 have opposing functions in the regulation of PCNA 
monoubiquitination and are important for determining the ulti-
mate ubiquitination status of PCNA. The mechanisms that reg-
ulate this balance require further investigation.
Although most known factors involved in TLS are con-
served from yeast to humans, the counterpart of SIVA1 protein 
is only found in higher eukaryotes. The reason for this difference 
between yeast and human cells is not yet clear but is likely to 
reflect a need for additional levels of control in mammalian cells. 
Previous studies have shown that limited PCNA monoubiquitina-
tion could be achieved in the absence of DNA, and significant 
PCNA monoubiquitination occurred only when PCNA is loaded 
onto DNA by RFC (Watanabe et al., 2004; Garg and Burgers, 
2005; Haracska et al., 2006; Unk et al., 2006, 2008; Hibbert et al., 
2011). In an in vitro ubiquitination assay using purified proteins, 
we showed that SIVA1 could promote RAD18-dependent PCNA 
monoubiquitination in the absence of DNA. Given that SIVA1 
facilitates RAD18–PCNA complex assembly in vivo and in vitro, 
we speculate that SIVA1 may also enhance RAD18-dependent 
monoubiquitination of RFC-loaded PCNA. Further studies will 
be conducted to consolidate this working model.
It has been previously reported that SIVA1 regulates cell 
proliferation and participates in p53-dependent apoptosis (Du 
et al., 2009; Resch et al., 2009; Iorio-Morin et al., 2012; Wang 
et al., 2013). In contrast, we found that SIVA1 depletion does 
not significantly affect cell proliferation and cell cycle distribu-
tion (Fig. S3, A and C; and Fig. S5). The basis for these discrep-
ancies is not clear, and additional experiments will be required 
to clarify the issue.
Using the SupF suppressor tRNA gene as the mutagenesis 
reporter gene, we found that SIVA1 depletion resulted in a hy-
permutator phenotype. Although it is not currently clear how 
SIVA1 suppresses mutagenesis, given that both SIVA1 and Pol 
(Durando et al., 2013) forms a complex with RAD18, we specu-
late that SIVA1 may bind directly or indirectly to Pol and may 
favor the recruitment of Pol to monoubiquitinated PCNA, 
thereby facilitating the error-free bypass of UV lesions. How-
ever, we cannot exclude the possibility that SIVA1 may have 
other roles in suppressing mutagenesis.
In summary, we have identified a function for SIVA1 as 
an adaptor for the E3 ligase RAD18, showing that collabora-
tion of SIVA1 and RAD18 controls the level of PCNA mono-
ubiquitination. These findings will provide new insights into the 
with PCNA through a highly conserved putative PIP box. Sec-
ond, cells depleted of SIVA1 showed marked increases in cellu-
lar sensitivity to UV treatment. Third, SIVA1 depletion largely 
prevented the formation of Pol foci after UV treatment. Fourth, 
SIVA1 promotes RAD18-mediated PCNA monoubiquitination 
in vivo and in vitro. Finally, depletion of SIVA1 resulted in a 
marked decrease in PCNA monoubiquitination, which was ac-
companied by reduced RAD18–PCNA complex formation. Our 
data are consistent with a model in which SIVA1 serves as a mo-
lecular bridge between RAD18 and PCNA, thus targeting the 
E3 ligase activity of RAD18 onto PCNA (Fig. 8 F).
A key event in the regulation of TLS is the monoubiqui-
tination of PCNA, a homotrimeric protein that acts as an auxil-
iary factor for DNA polymerases. Upon UV damage, PCNA is 
monoubiquitinated by the RAD18–RAD6 complex. This modi-
fication thus provides a platform for recruiting repair factors as 
well as specialized translesion DNA polymerases, which op-
erate to bypass bulky DNA adducts during DNA replication. 
Besides the RAD18–RAD6 complex, many other proteins, in-
cluding RPA (Davies et al., 2008), Claspin (Yang et al., 2008), 
CHK1 (Yang et al., 2008), C1orf124/Spartan/DVC1 (Centore 
et al., 2012; Davis et al., 2012; Ghosal et al., 2012; Juhasz 
et al., 2012; Machida et al., 2012; Mosbech et al., 2012), NBS1 
(Yanagihara et al., 2011), and Pol (Durando et al., 2013), are 
also required for efficient PCNA monoubiquitination. Most of 
these proteins are involved directly or indirectly in recruiting 
RAD18 to stalled replication forks. In contrast, SIVA1 serves 
as an adaptor that bridges RAD18 to PCNA and is not required 
for RAD18 nuclear foci formation and chromatin recruitment. 
Based on these findings, we propose that, in response to UV 
damage, single-stranded DNA regions are exposed and are coated 
with RPA at stalled replication forks. Through its interaction 
with RPA, NBS1, and/or other auxiliary factors, RAD18 is re-
cruited to these stalled replication forks. SIVA1 then serves as a 
molecular bridge between RAD18 and PCNA, thus targeting the 
E3 ligase activity of RAD18 onto PCNA (Fig. 8 F). However, 
in the absence of SIVA1, although RAD18 is still efficiently 
recruited to UV damage sites, it fails to interact efficiently with 
PCNA, leading to defects in PCNA monoubiquitination and 
subsequent Pol recruitment and TLS activation (Fig. 8 F).
Equally important as PCNA monoubiquitylation is PCNA 
deubiquitylation, which is performed by USP1 in a heterodi-
meric complex with its cofactor UAF1 (Huang et al., 2006; Cohn 
et al., 2007; Kim et al., 2009). Depletion of USP1 or UAF1 re-
sults in increased levels of monoubiquitinated PCNA both in 
the presence and absence of DNA damage. PCNA deubiquity-
lation also requires the PCNA-binding protein hELG1 (Lee 
et al., 2010; Parnas et al., 2010; Yang et al., 2011). Several studies 
defective in RAD18 binding failed to rescue Pol foci formation in cells with SIVA1 depletion. A XP30RO-Pol–derivative cell line stably expressing HA-
tagged siRNA#1-resistant wild-type SIVA1 or the deletion mutant defective in RAD18 binding was generated. The resulting cell line was transfected twice 
with the indicated siRNAs and was induced by doxycycline addition for 24 h before 50 J/m2 UV treatment. 1 h later, cells were fixed and processed for 
Pol immunofluorescence. (B) Representative Pol foci were shown. Bar, 10 µm. (C) Quantification results were the mean of three independent experiments 
and were presented as means ± SD. More than 100 cells were counted in each experiment. (D and E) SIVA1 and RAD18 function in the same pathway. 
HeLa cells transfected with the indicated siRNAs were treated with increasing doses of UV. Survival curves are shown for the indicated cell lines. Data are 
presented as means ± SD from three different experiments. (F) Model depicting the molecular function of SIVA1 in regulating TLS as described under the 
Discussion section. SiCon, siRNA control; ub, ubiquitin.
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the extract was centrifuged at 18,000 rpm for 40 min. The supernatant 
was collected and incubated with amylose resins for 2 h at 4°C. The bound 
protein was eluted with lysis buffer containing 10 mM maltose. Full-length 
RAD18 was cloned into the pET28-N-His-SUMO vector (EMD Millipore) for 
the expression of His-SUMO–tagged RAD18 in E. coli. The SUMO tag on 
RAD18 was able to improve its solubility to allow expression and purifica-
tion in the absence of RAD6 (Hibbert et al., 2011). Cells were harvested 
and resuspended in lysis buffer (20 mM Hepes, 300 mM NaCl, 1% Triton 
X-100, and 1 µg/ml each of leupeptin, aprotinin, and pepstatin). After 
sonicating, the extract was centrifuged at 18,000 rpm for 40 min. The su-
pernatant was collected and incubated with cobalt agarose for 2 h at 4°C. 
After washing the beads with washing buffer (20 mM Hepes, 500 mM 
NaCl, 1% Triton X-100, 5 mM imidazole, and 1 µg/ml each of leupeptin, 
aprotinin, and pepstatin), the bound protein was eluted with lysis buffer 
containing 200 mM imidazole.
Coimmunoprecipitation and Western blotting
For whole-cell extracts, the cells were solubilized in NETN lysis buffer sup-
plemented with 50 U/µl Benzonase, protease inhibitors, and phosphatase 
inhibitors. After removal of cell debris by centrifugation, the soluble fractions 
were collected. For Flag immunoprecipitations, a 0.8-ml aliquot of lysate 
was incubated with 1 µg of the Flag monoclonal antibody and 25 µl of 
a 1:1 slurry of protein A–Sepharose for 2 h at 4°C. For endogenous im-
munoprecipitations, 1 mg of the whole-cell extract was incubated with 25 µl 
of a 1:1 slurry of protein A–Sepharose coupled with 2 µl of the indicated 
antibodies for 2 h at 4°C. The Sepharose beads were washed three times 
with NTEN buffer, boiled in 2× SDS loading buffer, and resolved on SDS-
PAGE. Membranes were blocked in 5% milk in TBST (TBS with Tween) buffer 
and then probed with antibodies as indicated. To detect endogenous inter-
action between PCNA and RAD18, coimmunoprecipitation was conducted 
as described previously with modification (Kannouche et al., 2004). HeLa 
cells treated with the indicated siRNA were left untreated or treated with 
50 J/m2 UV and recovered for 1 h. Cells were then rinsed twice in cold PBS, 
incubated for 5 min on ice with gentle shaking in buffer A (100 mM NaCl, 
300 mM sucrose, 3 mM MgCl2, 10 mM Pipes, pH 6.8, 1 mM EGTA, 0.2% 
Triton X-100, and protease inhibitors). After Triton X-100 extraction, the ad-
hering cellular material was fixed by shaking with 1% formaldehyde in PBS 
for 10 min at 4°C. Glycine was added to a final concentration of 0.125 M for 
5 min to quench the cross-linking. Cellular material were then washed twice 
with cold PBS, harvested, centrifuged, and dissolved in 200 µl buffer B 
(50 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 0.1% SDS). After 10-min incu-
bation on ice, the samples were sonicated to shear the DNA to 200–1,500 bp 
and diluted five times with dilution buffer (50 mM Tris-HCl, pH 7.5, 100 mM 
NaCl, 5 mM EDTA, and 0.2% Triton X-100). Redissolved proteins were 
incubated with monoclonal mouse anti-PCNA antibody overnight at 4°C and 
then with 30 µl of protein A–Sepharose. 2 h later, the beads were washed 
three times with dilution buffer and boiled in 2× SDS loading buffer, and the 
bound proteins were analyzed by electrophoresis and immunoblotting.
RNAi
All siRNAs were synthesized by Thermo Fisher Scientific. The siRNAs were 21 
bp, and sequences are as follows: SIVA1 siRNA#1, 5-CCCUGUGUGGC-
CUCGUGGAdTdT-3; SIVA1 siRNA#2, 5-GGCGGUCUGCGGUCAGU-
GUdTdT-3; RAD18 siRNA, 5-ACUCAGUGUCCAACUUGCUdTdT-3; 
USP1 siRNA, 5-GAAAUACACAGCCAAGUAAUU-3; and control siRNA, 
5-UUCAAUAAAUUCUUGAGGUUU-3. The siRNA-resistant wild-type 
and mutant SIVA1 constructs were generated by changing six nucleo-
tides in the SIVA1 siRNA#1-targeting region (C453T, G456A, T459C, 
C462T, C465A, and G468A substitutions). The siRNA transfection was 
performed with 100 nM siRNA duplexes using Lipofectamine RNAiMAX 
(Invitrogen) following the manufacturer’s instructions. Transfection was 
repeated twice with an interval of 24 h to achieve the maximal RNAi ef-
fect. Lentiviral nonsilencing control shRNA and shRNA target sets were 
purchased from Thermo Fisher Scientific. The PCNA targeting sequences 
are #1, 5-AGACAAGTAATGTCGATAA-3, and #2, 5-TCAGTATGTCT-
GCAGATGT-3. The shRNAs were packaged into lentiviruses by cotrans-
fecting with packaging plasmids pMD2G and pSPAX2 (provided by 
S. Zhou, Baylor College of Medicine, Houston, TX) into HEK293T cells. 
48 h after transfection, the supernatant was collected for infection of HeLa 
cells. Infection was repeated twice with an interval of 24 h to achieve 
maximal infection efficiency.
Immunofluorescence staining
Indirect immunofluorescence was performed as previously described 
(Huang et al., 2009; Liu et al., 2010; Wan et al., 2013). HeLa or XP30RO 
(gift from C. Guo, Beijing Institute of Genomics, Chinese Academy of Sciences, 
molecular mechanisms of the replicative bypass of base damage 
to DNA by TLS, which is critically important for the mainte-
nance of genomic integrity and tumor suppression.
Materials and methods
Antibodies
Rabbit polyclonal anti-SIVA1, anti-USP1, and anti-UAF1 antibodies were gen-
erated by immunizing rabbits with MBP-SIVA1 (residues 1–175), MBP-USP1 
(residues 351–785), or MBP-UAF1 (residues 400–677) fusion proteins ex-
pressed and purified from E. coli, respectively. Antisera were affinity purified 
using an immobilization and purification kit (AminoLink Plus; Thermo Fisher 
Scientific). Anti-RAD18 and anti-RAD6A antibodies were purchased from 
Bethyl Laboratories, Inc. Anti-PCNA and anti-Myc (9E10) antibodies were pur-
chased from Santa Cruz Biotechnology, Inc. and Covance, respectively. Anti-
GAPDH, anti-H3, and anti-HA antibodies were purchased from EMD Millipore. 
The anti-Flag (M2) antibody was purchased from Sigma-Aldrich.
Cell culture and transfection
HEK293T and HeLa cells were maintained in DMEM supplemented with 
10% fetal bovine serum and 1% penicillin and streptomycin. Cell transfec-
tion was performed using Lipofectamine 2000 (Invitrogen) following the 
manufacturer’s protocol.
Constructs
SIVA1, PCNA, and RAD18 cDNAs were obtained from Thermo Fisher Scien-
tific. The PCR-amplified DNA fragment containing wild-type SIVA1, RAD18, or 
PCNA was subcloned into the pDONR201 vector using Gateway Technology 
(Invitrogen). Site-directed mutagenesis was performed according to standard 
procedures to obtain the SIVA1 mutants. For transient expression of PCNA, 
RAD18, SIVA1, or its mutants, the corresponding fragment in the entry vector 
was transferred into a Gateway-compatible destination vector (Invitrogen), 
which harbors either an N-terminal triple-epitope tag (S protein tag, Flag epit-
ope tag, and Streptavidin-binding peptide tag) or an N-terminal Myc tag or 
HA tag. All clones were sequenced to verify desired mutations.
The establishment of stable cell lines and affinity purification  
of SFB-tagged protein complexes
HEK293T cells were transfected with plasmids encoding SFB-tagged SIVA1 
or PCNA. Cell lines stably expressing tagged proteins were selected by 
culturing in medium containing 2 µg/ml puromycin and confirmed by 
immunoblotting and immunostaining. For affinity purification, HEK293T cells 
stably expressing tagged proteins were lysed with NETN buffer (20 mM 
Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, and 0.5% Nonidet P-40) 
containing Benzonase (EMD Millipore) for 20 min. The supernatants were 
cleared at 14,000 rpm to remove debris and then incubated with streptavidin-
conjugated beads (GE Healthcare) for 2 h at 4°C. The beads were washed 
three times with NETN buffer, and then, bead-bound proteins were eluted 
with NETN buffer containing 1 mg/ml biotin (Sigma-Aldrich). The elutes were 
incubated with S protein beads (EMD Millipore). The beads were again 
washed three times with NETN buffer and subjected to SDS-PAGE. Protein 
bands were excised and digested, and the peptides were analyzed by 
mass spectrometry.
Protein purification
SIVA1 wild type and mutants were cloned into pDONR201 as entry clones 
and were then transferred to pDEST15 destination vector (Invitrogen) for 
the expression of GST-tagged fusion protein in E. coli. Cells were grown 
at 37°C until log phase and were induced with 0.2 mM IPTG at 18°C for 
16 h. Cells were harvested and resuspended in lysis buffer (20 mM Tris-
HCl, 300 mM NaCl, 1% Triton X-100, 2 mM DTT, and 1 µg/ml each of 
leupeptin, aprotinin, and pepstatin) and then sonicated. The extract was 
centrifuged at 18,000 rpm for 40 min. The supernatant was collected 
and incubated with glutathione–Sepharose resin for 4 h at 4°C. After 
washing the beads with washing buffer (20 mM Tris-HCl, 500 mM NaCl, 
0.5% NP-40, 2 mM DTT, and 1 µg/ml each of leupeptin, aprotinin, and 
pepstatin), the bound protein was used for pull-down assays or eluted 
with 20 mM of reduced glutathione for in vitro ubiquitination assays. Full-
length PCNA or RAD6B was cloned into pDONR201 as an entry clone 
and was then transferred to the Gateway-compatible destination vector 
for the expression of MBP-tagged fusion protein in E. coli. Cells were 
harvested and resuspended in lysis buffer (20 mM Tris-HCl, 300 mM 
NaCl, 1% Triton X-100, 1 mM EDTA, 10 mM 2-mercaptoethanol, and 
1 µg/ml each of leupeptin, aprotinin, and pepstatin). After sonicating, 
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50 mM NaCl, and 0.1 mM DTT. The reactions were activated with 2 mM 
ATP and incubated at 30°C for 1 h. Proteins were resolved by SDS-PAGE 
and immunoblotted with the indicated antibodies.
BrdU incorporation assays
HeLa cells were transfected twice with the indicated siRNAs for an internal 
24 h. 48 h after the second transfection, 100 µM BrdU was added into the 
medium for 1 h. Cells were then harvested, washed with PBS, and fixed 
with ice-cold 70% ethanol overnight. Once centrifuged, cells were washed 
with PBS. DNA was denatured with 2.5 M HCl for 1 h at room tempera-
ture. After washing three times with PBS, cells were incubated in mouse 
anti-BrdU antibody (Roche) diluted 1:100 in blocking buffer (PBS + 0.1% 
Triton X-100 + 5% BSA) for 12 h followed by 3× wash with blocking buffer 
containing 500 mM NaCl. FITC-conjugated goat anti–mouse IgG (1:100; 
Jackson ImmunoResearch Laboratories, Inc.) was added and incubated 
for 4 h. After washing with blocking buffer containing 500 mM NaCl, 
cells were resuspended in PBS containing 20 µg/ml propidium iodide and 
200 µg/ml RNase A at 37°C for 20 min. Cell cycle distribution was ana-
lyzed on a flow cytometer (FACScan; Beckman Coulter).
Quantitative RT-PCR
Total RNA was extracted using the GenElute Mammalian Total RNA Mini-
prep kit (Sigma-Aldrich). Purified RNA was then reverse transcribed to 
cDNA by using SuperScript III First-Strand Synthesis System for RT-PCR (Invi-
trogen). Quantitative PCR was performed on an RT-PCR system (7500; Ap-
plied Biosystems) using the Power SYBR Green PCR Master Mix detection 
system (Applied Biosystems) with the following program: 50°C for 2 min, 
95°C for 10 min, 95°C for 15 s, and 60°C for 1 min for 40 cycles. GAPDH 
was chosen as an internal control for the normalization of the total cDNA. 
The primers used were as follows: GAPDH forward, 5-CGACCACTTTGT-
CAAGCTCA-3, and reverse, 5-TTACTCCTTGGAGGCCATGT-3; SIVA1 
forward, 5-CAGATGCTGATTGGACCAGA-3, and reverse, 5-CATGAG-
GAACAGGCAATGG-3; and PCNA forward, 5-TTGCACTGAGGTACCT-
GAACTT-3; and reverse, 5-TGTCCCATATCCGCAATTTT-3.
Online supplemental material
Fig. S1 shows that SIVA1 interacts with PCNA and demonstrates the speci-
ficity of the anti-SIVA1 antibody. Fig. S2 shows that SIVA1 depletion af-
fects Pol foci formation. Fig. S3 shows that SIVA1 depletion does not 
markedly affect cell proliferation. Fig. S4 shows that residues 331–375 of 
RAD18 are responsible for SIVA1 binding. Fig. S5 shows that SIVA1-
depleted cells complemented with wild type or 2 mutant of SIVA1 have 
comparable cell cycle profiles. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201311007/DC1.
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